Alnara

Allena

This biopharmaceutical company develops oral enzyme therapeutics for patients with rare and severe metabolic and kidney disorders, such as hyperoxaluria.

Anthera

This biopharmaceutical company develops and commercialises medicines to treat patients suffering from inflammation, autoimmune diseases, and exocrine pancreatic insufficiency due to cystic fibrosis.

Alentar

This company develops therapeutic agents to reverse goblet cell hyperplasia for patients with cystic fibrosis and other pulmonary conditions.

Alcresta

This company manufactures enzyme-based cartridges for enteral feeding tubes to assist fat absorption in patients with rare diseases and pancreatic insufficiency.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Akero Therapeutics

This company develops metabolic disease treatments for patients with metabolic dysfunction-associated steatohepatitis and other liver conditions.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.